Clinical Trial

A Study of Luspatercept in People With Anemia

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The researchers are doing this study to test whether luspatercept works to improve hemoglobin levels in people with anemia caused by chronic kidney disease (CKD). The researchers will also test whether luspatercept is a safe treatment that causes few or mild side effects in participants.
Trial Details
NCT Number NCT07725497
Lead Sponsor Memorial Sloan Kettering Cancer Center
Collaborators: Bristol-Myers Squibb
Conditions Anemia, Chronic Kidney Disease
Enrollment 30 participants
Start Date 2026-07-20
Primary Completion 2029-07 (estimated)
Study Completion 2029-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-24